AAPG Stock Analysis: Buy, Sell, or Hold?
AAPG - Ascentage Pharma Group International American Depository Shares
$16.71
-0.29 (-1.71%)
▼
5d:
-8.19%
30d:
-13.53%
90d:
-15.52%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 19, 2026
0d
Get Alerted When AAPG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AAPG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AAPG shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AAPG is currently trading at $16.71, which is considered oversold relative to its 30-day fair value range of $17.29 to $19.00.
Technical Outlook: Technically, AAPG is in a strong downtrend. The price is currently testing key support at $16.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AAPG scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $47.44 (+183.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AAPG is in a strong downtrend. The price is currently testing key support at $16.70. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AAPG scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $47.44 (+183.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$17.29 -
$19.00
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 183.9% below Wall St target ($47.44)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$17.29 -
$19.00
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$16.70
Resistance Level
$19.19
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.40
Wall Street Target
$47.44
(+183.9%)
Revenue Growth (YoY)
29.3%
Profit Margin
-228.5%
Share & Embed Analysis
Last updated: August 25, 2026 3:45 AM ET
Data refreshes hourly during market hours. Next update: 4:45 AM
Data refreshes hourly during market hours. Next update: 4:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AAPG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 39 SELL |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 46 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 45 HOLD |
